Alzheimer Beta/A4 Amyloid Precursor Protein in Human Brain: Aging-associated Increases in Holoprotein and in a Proteolytic Fragment

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Oct 15

PMID 1924350

Citations 20

Authors

C Nordstedt

S E Gandy

I Alafuzoff

G L Caporaso

K Iverfeldt

J A Grebb

B Winblad

P Greengard

Affiliations

Soon will be listed here.

Abstract

Alzheimer beta/A4 amyloid precursor protein (APP) has been suggested to play a central role in the pathogenesis of Alzheimer disease. We have measured the content of different species of APP holoprotein and carboxyl-terminal fragments in human brains from young individuals, nondemented aged individuals, and aged individuals with Alzheimer disease. By using an antibody directed against the cytoplasmic domain of APP, five species were resolved. Three of these, of molecular masses 106, 113, and 133 kDa, represent presumptive immature and mature isoforms of APP holoprotein. Two smaller proteins, of molecular masses 15 and 19 kDa, represent presumptive proteolytic carboxyl-terminal fragments of APP. The 133-, 113-, 106-, and 15-kDa species were found in both grey and white matter, whereas the 19-kDa species was found only in grey matter. Total APP immunoreactivity (sum of all five species) and the levels of the 113-, 106-, and 15-kDa species were not significantly different in brain samples from young individuals, nondemented aged individuals, and aged individuals with Alzheimer disease. In contrast, the levels of the 133- and 19-kDa species increased 2- to 3-fold with age. A correlation was observed between the levels of the 133- and 19-kDa species, suggesting a possible precursor-product relationship. The size of the 19-kDa fragment indicated that it might have an intact beta/A4 domain and therefore be amyloidogenic. The age-dependent increase either in a mature APP isoform and/or in a putative amyloidogenic fragment could explain why Alzheimer disease is associated with advanced age.

Citing Articles

Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.

Koss D, Jones G, Cranston A, Gardner H, Kanaan N, Platt B Acta Neuropathol. 2016; 132(6):875-895.

PMID: 27770234 PMC: 5106509. DOI: 10.1007/s00401-016-1632-3.

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.

Kurbatskaya K, Phillips E, Croft C, Dentoni G, Hughes M, Wade M Acta Neuropathol Commun. 2016; 4:34.

PMID: 27036949 PMC: 4818436. DOI: 10.1186/s40478-016-0299-2.

Aging, Alzheimer's, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50.

Aboud O, Parcon P, DeWall K, Liu L, Mrak R, Griffin W Front Cell Neurosci. 2015; 9:103.

PMID: 25859183 PMC: 4373372. DOI: 10.3389/fncel.2015.00103.

Hydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway.

Nagpure B, Bian J PLoS One. 2014; 9(2):e88508.

PMID: 24523906 PMC: 3921165. DOI: 10.1371/journal.pone.0088508.

Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism.

Karuppagounder S, Xu H, Pechman D, Chen L, DeGiorgio L, Gibson G Neurochem Res. 2008; 33(7):1365-72.

PMID: 18317926 PMC: 2870991. DOI: 10.1007/s11064-008-9594-z.

References

Wisniewski K, Dalton A, McLachlan C, Wen G, Wisniewski H . Alzheimer's disease in Down's syndrome: clinicopathologic studies. Neurology. 1985; 35(7):957-61. DOI: 10.1212/wnl.35.7.957. View

Masters C, Simms G, Weinman N, Multhaup G, McDonald B, Beyreuther K . Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985; 82(12):4245-9. PMC: 397973. DOI: 10.1073/pnas.82.12.4245. View

Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M . Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150(1):76-85. DOI: 10.1016/0003-2697(85)90442-7. View

Goldgaber D, Lerman M, MCBRIDE O, Saffiotti U, Gajdusek D . Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987; 235(4791):877-80. DOI: 10.1126/science.3810169. View

Tanzi R, Gusella J, Watkins P, BRUNS G, St George-Hyslop P, Van Keuren M . Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987; 235(4791):880-4. DOI: 10.1126/science.2949367. View

Kang J, Lemaire H, Unterbeck A, Salbaum J, Masters C, Grzeschik K . The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987; 325(6106):733-6. DOI: 10.1038/325733a0. View

Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B . Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol. 1987; 74(3):209-25. DOI: 10.1007/BF00688184. View

Ponte P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K . A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988; 331(6156):525-7. DOI: 10.1038/331525a0. View

Tanzi R, McClatchey A, Lamperti E, Gusella J, Neve R . Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988; 331(6156):528-30. DOI: 10.1038/331528a0. View

10.

Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H . Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988; 331(6156):530-2. DOI: 10.1038/331530a0. View

11.

Dyrks T, Weidemann A, Multhaup G, Salbaum J, Lemaire H, Kang J . Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J. 1988; 7(4):949-57. PMC: 454420. DOI: 10.1002/j.1460-2075.1988.tb02900.x. View

12.

Gandy S, Czernik A, Greengard P . Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A. 1988; 85(16):6218-21. PMC: 281937. DOI: 10.1073/pnas.85.16.6218. View

13.

Selkoe D, Podlisny M, Joachim C, Vickers E, Lee G, Fritz L . Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A. 1988; 85(19):7341-5. PMC: 282182. DOI: 10.1073/pnas.85.19.7341. View

14.

Weidemann A, Konig G, Bunke D, Fischer P, Salbaum J, Masters C . Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 1989; 57(1):115-26. DOI: 10.1016/0092-8674(89)90177-3. View

15.

Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R . Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med. 1989; 320(22):1446-52. DOI: 10.1056/NEJM198906013202203. View

16.

Yankner B, Dawes L, Fisher S, Neve R . Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989; 245(4916):417-20. DOI: 10.1126/science.2474201. View

17.

Palmert M, Siedlak S, Podlisny M, Greenberg B, Shelton E, Chan H . Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein. Biochem Biophys Res Commun. 1989; 165(1):182-8. DOI: 10.1016/0006-291x(89)91052-8. View

18.

Oltersdorf T, Ward P, Henriksson T, Beattie E, Neve R, Lieberburg I . The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J Biol Chem. 1990; 265(8):4492-7. View

19.

Koo E, Sisodia S, Cork L, Unterbeck A, Bayney R, Price D . Differential expression of amyloid precursor protein mRNAs in cases of Alzheimer's disease and in aged nonhuman primates. Neuron. 1990; 4(1):97-104. DOI: 10.1016/0896-6273(90)90446-m. View

20.

Sisodia S, Koo E, Beyreuther K, Unterbeck A, Price D . Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 1990; 248(4954):492-5. DOI: 10.1126/science.1691865. View